TURNOVER (x1000 SEK)
NET PROFIT (x1000 SEK)
Pensa Pharma AB
Closing information (x1000 SEK)
| Closing information | 2024/03 | 2023/03 | 2021/12 |
| Turnover |
15,164
|
31,983
|
39,243 |
| Financial expenses |
18
|
101
|
1 |
| Earnings before taxes |
-1,690
|
-3,705
|
1,076 |
| EBITDA |
1,387
|
-3,330
|
1,007 |
| Total assets |
16,979
|
28,604
|
29,118 |
| Current assets |
16,953
|
22,509
|
17,725 |
| Current liabilities |
3,268
|
10,271
|
6,991 |
| Equity capital |
13,711
|
18,333
|
22,127 |
| - share capital |
1,000
|
1,000
|
1,000 |
| Employees (average) |
0
|
0
|
0 |
Financial ratios
| Fiscal year | 2024/03 | 2023/03 | 2021/12 |
| Solvency |
80.8%
|
64.1%
|
76.0% |
| Turnover per employee | |||
| Profit as a percentage of turnover |
-11.1%
|
-11.6%
|
2.7% |
| Return on assets (ROA) |
-9.8%
|
-12.6%
|
3.7% |
| Current ratio |
518.8%
|
219.2%
|
253.5% |
| Return on equity (ROE) |
-12.3%
|
-20.2%
|
4.9% |
| Change turnover |
-16,819
|
-7,260
|
16,805 |
| Change turnover % |
-53%
|
-19%
|
75% |
| Chg. No. of employees |
0
|
0
|
0 |
| Chg. No. of employees % |
Total value of public sale
| Fiscal year | 2024/03 | 2023/03 | 2021/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.